ClinConnect ClinConnect Logo
Search / Trial NCT03901417

Comparison of 1550nm Fractional Laser Alone Versus in Combination With Microneedling for the Treatment of Acne Scars

Launched by MASSACHUSETTS GENERAL HOSPITAL · Apr 1, 2019

Trial Information

Current as of April 25, 2025

Unknown status

Keywords

ClinConnect Summary

Acne vulgaris is a highly prevalent dermatologic disorder that affects up to 90% percent of the population at some point in their lives to varying degrees. Acne scarring is an unfortunate complication of the inflammation that results if acne is not sufficiently treated. Classically, acne scarring has been described as either atrophic, hypertrophic, keloidal, or pigmented. Atrophic is by far the most common type of acne scarring and is subdivided into boxcar, rolling, and icepick subtypes. The presence of acne scarring has been associated with a significant decrease in patient well-being and...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All gender patients
  • Age older than 18 years
  • Fitzpatrick skin types I-III
  • Facial acne scarring of grades III-IV
  • Both sides of the face should have similar amount and severity of acne scarring
  • Exclusion Criteria:
  • History of keloidal scarring
  • Localized or active infection in the treatment region
  • Immunodeficiency disorders
  • Porphyria or light sensitivity
  • Connective tissue disorders.
  • Pregnant or nursing
  • Recent isotretinoin use within the past 6 months
  • Renal Disease
  • Allergies to lidocaine, tetracaine, valacyclovir

Trial Officials

Mathew Avram, MD

Principal Investigator

Massachusetts General Hospital

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials